azathioprine has been researched along with Body Weight in 71 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
Excerpt | Relevance | Reference |
---|---|---|
"In order to evaluate whether immunosuppressive agents such as mycophenolate mofetil (MMF) and azathioprine would differently influence the outcome of the renal transplants, we prospectively analyzed the incidence of acute rejection episodes, cytomegalovirus infection within the first 6 months following renal transplantation and 5 yr graft survival rate after minimizing influences of donor factors by grafting the same cadaveric donor kidney." | 7.73 | The influence of mycophenolate mofetil and azathioprine on the same cadaveric donor renal transplantation. ( Joh, JW; Kim, SJ; Lee, DS; Lee, HH; Lee, KW; Lee, SK, 2005) |
" It was evaluated, in comparison with azathioprine (AZA) and methylprednisolone acetate (MPA), for its therapeutic effects on the glomerulonephritis induced in rats by rabbit antiserum against the rat glomerular basement membrane." | 7.68 | Therapeutic effects of leflunomide, a new antirheumatic drug, on glomerulonephritis induced by the antibasement membrane antibody in rats. ( Gotoh, K; Hayashi, S; Inazu, M; Inoue, T; Ogawa, T, 1991) |
"The present study was made to investigate the antinephritic effect of mizoribine in comparison to that of azathioprine by using the nephrotic type of anti-rat glomerular basement membrane rabbit serum (anti-GBM serum)-induced nephritis in rats." | 7.66 | Studies on antinephritic effect of mizoribine (p-INN, Bredinin), a new immunosuppressive agent, and azathioprine (1) effect on the nephrotic type of anti-GBM nephritis in rats. ( Ito, M; Okamoto, K; Suzuki, Y, 1983) |
"The incidence of posttransplant diabetes mellitus (PTDM) was compared in three groups of renal transplant recipients: nondiabetic patients who had been randomized between 1980 and 1983 to receive antilymphoblast globulin (ALG), azathioprine (AZA), and prednisone (P) (group 1) or cyclosporine (CsA) plus prednisone (group 2)." | 5.06 | The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. ( Ascher, N; Boudreaux, JP; Canafax, DM; Fryd, DS; McHugh, L; Najarian, JS; Payne, W; Simmons, RL; Sutherland, DE, 1987) |
"In order to evaluate whether immunosuppressive agents such as mycophenolate mofetil (MMF) and azathioprine would differently influence the outcome of the renal transplants, we prospectively analyzed the incidence of acute rejection episodes, cytomegalovirus infection within the first 6 months following renal transplantation and 5 yr graft survival rate after minimizing influences of donor factors by grafting the same cadaveric donor kidney." | 3.73 | The influence of mycophenolate mofetil and azathioprine on the same cadaveric donor renal transplantation. ( Joh, JW; Kim, SJ; Lee, DS; Lee, HH; Lee, KW; Lee, SK, 2005) |
" It was evaluated, in comparison with azathioprine (AZA) and methylprednisolone acetate (MPA), for its therapeutic effects on the glomerulonephritis induced in rats by rabbit antiserum against the rat glomerular basement membrane." | 3.68 | Therapeutic effects of leflunomide, a new antirheumatic drug, on glomerulonephritis induced by the antibasement membrane antibody in rats. ( Gotoh, K; Hayashi, S; Inazu, M; Inoue, T; Ogawa, T, 1991) |
" Azathioprine in different doses, and cyclophosamide and methylprednisolone combinations did not result in predictable leukocytopenia without significant mortality." | 3.67 | Development of a leukocytopenic baby guinea pig model with azathioprine and cyclophosphamide. ( Cleveland, RP; Kumar, A; Leonard, MC, 1989) |
"The present study was made to investigate the antinephritic effect of mizoribine in comparison to that of azathioprine by using the nephrotic type of anti-rat glomerular basement membrane rabbit serum (anti-GBM serum)-induced nephritis in rats." | 3.66 | Studies on antinephritic effect of mizoribine (p-INN, Bredinin), a new immunosuppressive agent, and azathioprine (1) effect on the nephrotic type of anti-GBM nephritis in rats. ( Ito, M; Okamoto, K; Suzuki, Y, 1983) |
"To investigate whether AZA therapy is optimised by individualised dosing based on thiopurine methyltransferase (TPMT) activity and 6TGN concentrations." | 2.79 | Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn's disease. ( Bentsen, JL; Dassopoulos, T; Dubinsky, MC; Galanko, JA; Hanauer, SB; Martin, CF; Sandler, RS; Seidman, EG, 2014) |
"Refractory sprue is a rare and severe malabsorptive disorder that mimics celiac disease but is refractory to a gluten-free diet and is without initial evidence of overt lymphoma." | 2.70 | Azathioprine in refractory sprue: results from a prospective, open-label study. ( Bai, JC; Cabanne, A; Capucchio, M; Cherñavsky, A; Fiorini, A; Kogan, Z; Mauriño, E; Mazure, R; Niveloni, S; Pedreira, S; Reyes, H; Smecuol, E; Vazquez, H, 2002) |
" Additionally, the review addresses the benefits and risks of routine measurement of thiopurine methyltransferase enzyme activity or genotype before starting thiopurine therapy compared with empiric weight-based dosing and explores the performance of different trough drug concentrations for anti-tumor necrosis factor agents and thiopurines to inform clinical decision making when applying TDM in a reactive setting." | 2.55 | American Gastroenterological Association Institute Technical Review on the Role of Therapeutic Drug Monitoring in the Management of Inflammatory Bowel Diseases. ( Falck-Ytter, Y; Herfarth, H; Katz, J; Singh, S; Vande Casteele, N, 2017) |
"Azathioprine (AZA) is a cytotoxic immunosuppressive drug used in the prevention of rejection in organ transplants and the treatment of auto-immune diseases." | 1.35 | The haemotoxicity of azathioprine in repeat dose studies in the female CD-1 mouse. ( Chen, CM; Gibson, FM; Marway, HK; McKeag, S; Mifsud, CV; Molyneux, G; Pilling, AM; Turton, JA; Whayman, MJ, 2008) |
"Univariate analysis identified the duration of transplant, papilla bleeding index, creatinine serum concentration, azathioprine and prednisolone dosage as risk factors for overgrowth severity." | 1.33 | Risk factors for gingival overgrowth in patients medicated with ciclosporin in the absence of calcium channel blockers. ( Ellis, JS; Seymour, RA; Thomason, JM, 2005) |
" In this study, we examined the dosing time-dependent alterations in the pharmacokinetics and pharmacodynamics of Miz." | 1.31 | Dosing time-dependent pharmacological effects of anti-metabolites for rat cardiac graft. ( Fujimura, A; Higuchi, S; Hishikawa, S; Kobayashi, E; Sudoh, T; Sugimoto, K; Sunaga, K; To, H; Uchida, H; Xiu, DR, 2001) |
" Duration of treatment, dosage of drugs per kg body weight and serum cyclosporin levels were recorded." | 1.30 | Contribution of individual drugs to gingival overgrowth in adult and juvenile renal transplant patients treated with multiple therapy. ( Ashley, FP; Koffman, CG; Morel, A; Ogg, CS; Rigden, SP; Smith, D; Wilson, RF, 1998) |
" Differential analysis of white blood cells indicated a decline in lymphocyte number, in particular, with increased dosage of azathioprine." | 1.30 | Tilapia (Oreochromis niloticus) dosed with azathioprine display immune effects similar to those seen in mammals, including apoptosis. ( Gogal, RM; Holladay, SD; Robertson, JL; Smith, BJ; Smith, SA, 1999) |
"Azathioprine treatment alone did not alter ionized calcium, 1,25(OH)2VitD, or PTH levels." | 1.29 | Azathioprine alone is bone sparing and does not alter cyclosporin A-induced osteopenia in the rat. ( Armstrong, EC; Bryer, HP; Buchinsky, FJ; Epstein, S; Isserow, JA; Mann, GN; Romero, DF; Rucinski, B, 1995) |
"The diagnostic possibility of Crohn's disease in unusual sites should be considered in any child with unexplained failure to thrive." | 1.26 | Isolated gastroduodenal Crohn's disease in a ten-year-old girl. ( Malleson, P, 1980) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 47 (66.20) | 18.7374 |
1990's | 11 (15.49) | 18.2507 |
2000's | 11 (15.49) | 29.6817 |
2010's | 2 (2.82) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vande Casteele, N | 1 |
Herfarth, H | 1 |
Katz, J | 1 |
Falck-Ytter, Y | 1 |
Singh, S | 1 |
Dassopoulos, T | 1 |
Dubinsky, MC | 1 |
Bentsen, JL | 1 |
Martin, CF | 1 |
Galanko, JA | 1 |
Seidman, EG | 1 |
Sandler, RS | 1 |
Hanauer, SB | 1 |
Takae, Y | 1 |
Nishikawa, T | 1 |
Amagai, M | 1 |
Diamanti, A | 1 |
Basso, MS | 1 |
Gambarara, M | 1 |
Papadatou, B | 1 |
Bracci, F | 1 |
Noto, C | 1 |
Castro, M | 1 |
Ojogho, ON | 1 |
Sahney, S | 1 |
Cutler, D | 1 |
Baron, PW | 1 |
Abdelhalim, FM | 1 |
Hasan, SM | 1 |
Concepcion, W | 1 |
Mauriño, E | 1 |
Niveloni, S | 1 |
Cherñavsky, A | 1 |
Pedreira, S | 1 |
Mazure, R | 1 |
Vazquez, H | 1 |
Reyes, H | 1 |
Fiorini, A | 1 |
Smecuol, E | 1 |
Cabanne, A | 1 |
Capucchio, M | 1 |
Kogan, Z | 1 |
Bai, JC | 1 |
To, H | 1 |
Xiu, DR | 1 |
Hishikawa, S | 1 |
Uchida, H | 2 |
Sudoh, T | 1 |
Sunaga, K | 1 |
Sugimoto, K | 1 |
Higuchi, S | 1 |
Fujimura, A | 1 |
Kobayashi, E | 1 |
COSIMI, AB | 1 |
RECKLER, JM | 1 |
WADDELL, WR | 1 |
Borrelli, O | 1 |
Bascietto, C | 1 |
Viola, F | 1 |
Bueno de Mesquita, M | 1 |
Barbato, M | 1 |
Mancini, V | 1 |
Bosco, S | 1 |
Cucchiara, S | 1 |
Grebe, SO | 1 |
Mueller, TF | 1 |
Troeltsch, M | 1 |
Ebel, H | 1 |
Lange, H | 1 |
Joh, JW | 1 |
Lee, HH | 1 |
Lee, DS | 1 |
Lee, KW | 1 |
Lee, SK | 1 |
Kim, SJ | 1 |
Thomason, JM | 1 |
Seymour, RA | 1 |
Ellis, JS | 1 |
Molyneux, G | 1 |
Gibson, FM | 1 |
Chen, CM | 1 |
Marway, HK | 1 |
McKeag, S | 1 |
Mifsud, CV | 1 |
Pilling, AM | 1 |
Whayman, MJ | 1 |
Turton, JA | 1 |
Dardenne, M | 1 |
Savino, W | 1 |
Wade, S | 1 |
Kaiserlian, D | 1 |
Lemonnier, D | 1 |
Bach, JF | 1 |
Okamoto, K | 1 |
Ito, M | 1 |
Suzuki, Y | 1 |
Malleson, P | 1 |
De Waal, EJ | 1 |
Timmerman, HH | 1 |
Dortant, PM | 1 |
Kranjc, MA | 1 |
Van Loveren, H | 1 |
Bryer, HP | 1 |
Isserow, JA | 1 |
Armstrong, EC | 1 |
Mann, GN | 1 |
Rucinski, B | 1 |
Buchinsky, FJ | 1 |
Romero, DF | 1 |
Epstein, S | 1 |
Hilbrands, LB | 1 |
Hoitsma, AJ | 1 |
Koene, RA | 1 |
Heaf, JG | 1 |
Ladefoged, J | 1 |
Wilson, RF | 1 |
Morel, A | 1 |
Smith, D | 1 |
Koffman, CG | 1 |
Ogg, CS | 1 |
Rigden, SP | 1 |
Ashley, FP | 1 |
Lulin, M | 1 |
Yantang, L | 1 |
Gogal, RM | 1 |
Smith, BJ | 1 |
Robertson, JL | 1 |
Smith, SA | 1 |
Holladay, SD | 1 |
Molinaro, M | 1 |
Regazzi, MB | 1 |
Pasquino, S | 1 |
Rinaldi, M | 1 |
Iacona, I | 1 |
Campana, C | 1 |
Viganò, M | 1 |
Beaumont, JE | 1 |
Galla, JH | 1 |
Luke, RG | 1 |
Rees, ED | 1 |
Siegel, RR | 1 |
McMillen, MA | 1 |
Cerra, FB | 1 |
Baliah, T | 1 |
Anthone, S | 1 |
Anthone, R | 1 |
Menahan, LA | 1 |
Kemp, RG | 1 |
Scott, JR | 2 |
Ogawa, T | 1 |
Inazu, M | 1 |
Gotoh, K | 1 |
Inoue, T | 1 |
Hayashi, S | 1 |
Pirsch, JD | 1 |
Armbrust, MJ | 1 |
Knechtle, SJ | 1 |
Reed, A | 1 |
D'Alessandro, AM | 1 |
Sollinger, HW | 1 |
Belzer, FO | 1 |
Dammenhayn, L | 1 |
Haverich, A | 1 |
Demertzis, S | 1 |
Reimer, P | 1 |
Kemnitz, J | 1 |
Klebe, JG | 1 |
Marushak, A | 1 |
Bock, J | 1 |
Ito, A | 1 |
Mori, M | 1 |
Naito, M | 1 |
Kumar, A | 1 |
Leonard, MC | 1 |
Cleveland, RP | 1 |
Kupin, W | 2 |
Venkat, KK | 2 |
Oh, HK | 2 |
Hodson, EM | 1 |
Knight, JF | 1 |
Sheil, AG | 1 |
Roy, LP | 1 |
Dienst, S | 1 |
Boudreaux, JP | 1 |
McHugh, L | 1 |
Canafax, DM | 1 |
Ascher, N | 1 |
Sutherland, DE | 1 |
Payne, W | 1 |
Simmons, RL | 1 |
Najarian, JS | 2 |
Fryd, DS | 1 |
Smith, KP | 1 |
Zardiackas, LD | 1 |
Didlake, RH | 1 |
Gotjamanos, T | 1 |
Babington, RG | 1 |
Wedeking, PW | 1 |
Vetten, KB | 1 |
Mallinson, CN | 1 |
Candy, JC | 1 |
Cowan, R | 1 |
Prior, A | 1 |
Atkinson, JP | 1 |
Frank, MM | 1 |
Casey, TP | 1 |
Mathews, JD | 1 |
Buckley, JD | 1 |
Gledhill, VX | 1 |
Jursik, JJ | 1 |
De Quesada, AM | 1 |
Shires, DL | 1 |
Bradley, KP | 1 |
Papp, JP | 1 |
Watson, DW | 1 |
Bull, FE | 1 |
Kierfeld, G | 1 |
Mellin, P | 1 |
Schwalm, E | 1 |
Schreiber, M | 1 |
Schreiber, B | 1 |
Jakóbisiak, M | 1 |
Kamiński, M | 1 |
Kossakowska, AE | 1 |
Rymaszewska-Kossakowska, T | 1 |
Toledo-Pereyra, LH | 1 |
Idezuki, Y | 1 |
Goetz, FC | 1 |
Lillehei, RC | 2 |
Gault, MH | 1 |
Ackman, D | 1 |
Morehouse, D | 1 |
Dossetor, JB | 1 |
Koumans, RK | 1 |
Burke, JF | 1 |
Turcotte, JG | 1 |
Herrmann, TJ | 1 |
Haig, O | 1 |
O'Dell, C | 1 |
Cerny, J | 1 |
Greene, JA | 1 |
Rao, MM | 1 |
Meadows, R | 1 |
Rao, MD | 1 |
Knight, PR | 1 |
Cachera, JP | 1 |
Poulain, H | 1 |
Crepin, Y | 1 |
Fernandez, O | 1 |
Hollman, KH | 1 |
Halpern, B | 1 |
Kalter, SS | 1 |
Ratner, IA | 1 |
Britton, HA | 1 |
Vice, TE | 1 |
Eugster, AK | 1 |
Rodriguez, AR | 1 |
Freudenberg, J | 1 |
Ruiz, JO | 1 |
Schultz, LS | 1 |
Van Vroonhoven, TJ | 1 |
Malamud, DM | 1 |
Malt, RA | 1 |
Sokolowski, J | 2 |
Olszewski, W | 2 |
Orlowski, T | 1 |
Nielubowicz, J | 1 |
Gradowska, L | 1 |
Rowiński, W | 1 |
Klopotowska, E | 1 |
Rosenthale, ME | 1 |
Datko, LJ | 1 |
Kassarich, J | 1 |
Schneider, F | 1 |
Drucker, WR | 1 |
Jeejeebhoy, KN | 1 |
Frankel, HH | 1 |
Yamamoto, RS | 1 |
Weisburger, EK | 1 |
Weisburger, JH | 1 |
Schmidt, JG | 1 |
Lischka, G | 1 |
Worthington, M | 1 |
Baron, S | 1 |
Makulu, DR | 1 |
Wright, P | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Relationship Between Baseline Burden of Disease and Anti-TNF Drug Trough Levels in Ulcerative Colitis.[NCT03808506] | 0 participants (Actual) | Observational | 2019-09-01 | Withdrawn (stopped due to no recruitment during COVID pandemic) | |||
A Multi-site Trial of Azathioprine Dosing in Crohn's Disease[NCT00113503] | Phase 2 | 50 participants (Actual) | Interventional | 2005-07-31 | Terminated (stopped due to Insufficient enrollment) | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for azathioprine and Body Weight
Article | Year |
---|---|
American Gastroenterological Association Institute Technical Review on the Role of Therapeutic Drug Monitoring in the Management of Inflammatory Bowel Diseases.
Topics: Antibodies, Monoclonal; Azathioprine; Body Weight; Drug Monitoring; Humans; Immunosuppressive Agents | 2017 |
8 trials available for azathioprine and Body Weight
Article | Year |
---|---|
Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn's disease.
Topics: Adolescent; Adult; Azathioprine; Body Weight; Child; Crohn Disease; Double-Blind Method; Female; Hum | 2014 |
Azathioprine in refractory sprue: results from a prospective, open-label study.
Topics: Adult; Aged; alpha 1-Antitrypsin; Autoantibodies; Azathioprine; Biopsy, Needle; Body Weight; Celiac | 2002 |
Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
Topics: Adolescent; Antibodies, Monoclonal; Azathioprine; Blood Sedimentation; Body Height; Body Weight; C-R | 2004 |
The effect of immunosuppressive drugs on quality of life after renal transplantation.
Topics: Adult; Azathioprine; Body Weight; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; | 1995 |
Human placental lactogenic hormone as a parameter for placental function in renal transplanted women.
Topics: Azathioprine; Body Weight; Creatinine; Cyclosporins; Female; Fetus; Humans; Kidney Transplantation; | 1990 |
Cyclosporin A as sole immunosuppressive agent for renal transplantation in children: effect on catch-up growth.
Topics: Adolescent; Antilymphocyte Serum; Azathioprine; Body Weight; Child; Clinical Trials as Topic; Cyclos | 1989 |
The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Body Weight; Cyclosporins; Diabetes Mellitus; Drug Therap | 1987 |
Azathioprine treatment in Crohn's disease.
Topics: Adolescent; Adult; Azathioprine; Body Weight; Clinical Trials as Topic; Crohn Disease; Diarrhea; Fem | 1974 |
62 other studies available for azathioprine and Body Weight
Article | Year |
---|---|
Pemphigus mouse model as a tool to evaluate various immunosuppressive therapies.
Topics: Animals; Azathioprine; Body Weight; Cyclophosphamide; Cyclosporine; Desmoglein 3; Dexamethasone; Dis | 2009 |
Positive impact of blocking tumor necrosis factor alpha on the nutritional status in pediatric Crohn's disease patients.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Body Heig | 2009 |
Mycophenolate mofetil without antibody induction in pediatric renal transplantation.
Topics: Adolescent; Antilymphocyte Serum; Azathioprine; Body Weight; Cadaver; California; Child; Cyclosporin | 2002 |
Dosing time-dependent pharmacological effects of anti-metabolites for rat cardiac graft.
Topics: Animals; Area Under Curve; Azathioprine; Body Weight; Dose-Response Relationship, Drug; Drug Adminis | 2001 |
METABOLIC STUDIES ON RENAL HOMOGRAFT PATIENTS.
Topics: Allografts; Antimetabolites; Azathioprine; Blood Urea Nitrogen; Body Weight; Dactinomycin; Drug Ther | 1965 |
Effect of mycophenolate mofetil on kidney graft function and body weight in patients with chronic allograft nephropathy.
Topics: Albuminuria; Azathioprine; Body Weight; Creatinine; Cyclosporine; Drug Therapy, Combination; Graft S | 2004 |
The influence of mycophenolate mofetil and azathioprine on the same cadaveric donor renal transplantation.
Topics: ABO Blood-Group System; Adult; Azathioprine; Body Weight; Cadaver; Cytomegalovirus; Cytomegalovirus | 2005 |
Risk factors for gingival overgrowth in patients medicated with ciclosporin in the absence of calcium channel blockers.
Topics: Anti-Inflammatory Agents; Azathioprine; Body Weight; Creatinine; Cyclosporine; Dental Plaque Index; | 2005 |
The haemotoxicity of azathioprine in repeat dose studies in the female CD-1 mouse.
Topics: Animals; Apoptosis; Azathioprine; Body Weight; Bone Marrow Cells; Colony-Forming Units Assay; Diseas | 2008 |
In vivo and in vitro studies of thymulin in marginally zinc-deficient mice.
Topics: Animals; Azathioprine; Body Weight; Female; Mice; Mice, Inbred C57BL; Organ Size; T-Lymphocytes; Thy | 1984 |
Studies on antinephritic effect of mizoribine (p-INN, Bredinin), a new immunosuppressive agent, and azathioprine (1) effect on the nephrotic type of anti-GBM nephritis in rats.
Topics: Animals; Azathioprine; Basement Membrane; Body Weight; Immune Sera; Immunosuppressive Agents; Kidney | 1983 |
Isolated gastroduodenal Crohn's disease in a ten-year-old girl.
Topics: Azathioprine; Body Weight; Child; Crohn Disease; Duodenum; Female; Humans; Steroids; Stomach | 1980 |
Investigation of a screening battery for immunotoxicity of pharmaceuticals within a 28-day oral toxicity study using azathioprine and cyclosporin A as model compounds.
Topics: Administration, Oral; Animals; Azathioprine; Blood Cell Count; Body Weight; Bone Marrow; Bone Marrow | 1995 |
Azathioprine alone is bone sparing and does not alter cyclosporin A-induced osteopenia in the rat.
Topics: Animals; Azathioprine; Body Weight; Bone Diseases, Metabolic; Calcitriol; Calcium; Cyclosporine; Dis | 1995 |
Hyperfiltration, creatinine clearance and chronic graft loss.
Topics: Adolescent; Adult; Analysis of Variance; Azathioprine; Body Weight; Chi-Square Distribution; Creatin | 1998 |
Contribution of individual drugs to gingival overgrowth in adult and juvenile renal transplant patients treated with multiple therapy.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Analysis of Variance; Azathioprine; Body We | 1998 |
Comparison of the immunosuppressive and toxic effects of TII and azathioprine.
Topics: Animals; Atrophy; Azathioprine; Body Weight; China; Drugs, Chinese Herbal; Female; Graft Survival; H | 1998 |
Tilapia (Oreochromis niloticus) dosed with azathioprine display immune effects similar to those seen in mammals, including apoptosis.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Azathioprine; Blood Cell Count; Body Weight; Fl | 1999 |
Pharmacokinetics of tacrolimus during the early phase after heart transplantation.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Body Weight; Drug Therapy, Combination; Female; Heart Tra | 2001 |
Normal serum-lipids in renal-transplant patients.
Topics: Adolescent; Adult; Age Factors; Antigens; Azathioprine; Body Weight; Cholesterol; Creatine; Fasting; | 1975 |
Swine influenza vaccination in a dialysis and transplant population.
Topics: Adolescent; Adult; Aged; Antibody Formation; Azathioprine; Body Weight; Child; Creatinine; Female; G | 1978 |
The effect of several lymphocytotoxic agents on murine leukemogenesis.
Topics: Aging; Animals; Azathioprine; Body Weight; Cortisone; Dacarbazine; Leukemia, Experimental; Lymphocyt | 1978 |
The effect of immunosuppressive drugs and immunostimulating agents on reproductive performance.
Topics: Adjuvants, Immunologic; Animals; Azathioprine; BCG Vaccine; Body Weight; Cyclophosphamide; Female; F | 1977 |
Fetal growth retardation associated with maternal administration of immunosuppressive drugs.
Topics: Animals; Azathioprine; Body Weight; Cyclophosphamide; Depression, Chemical; Female; Fetal Diseases; | 1977 |
Therapeutic effects of leflunomide, a new antirheumatic drug, on glomerulonephritis induced by the antibasement membrane antibody in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Anti-Idiotypic; Azathioprine; Basement | 1991 |
Effect of steroid withdrawal on hypertension and cholesterol levels in living related recipients.
Topics: Azathioprine; Body Weight; Cholesterol; Creatinine; Cyclosporins; Humans; Hypertension; Immunosuppre | 1991 |
Growth of lung allografts after experimental transplantation.
Topics: Animals; Azathioprine; Body Weight; Cyclosporins; Graft Rejection; Immunosuppression Therapy; Lung; | 1991 |
Induction of uterine hemangioendothelioma and lymphoma in (C57BL/6N x C3H/2N)F1 mice by oral administration of azathioprine.
Topics: Administration, Oral; Animals; Azathioprine; Body Weight; Female; Hemangioendothelioma; Lymphoma; Ma | 1989 |
Development of a leukocytopenic baby guinea pig model with azathioprine and cyclophosphamide.
Topics: Animals; Azathioprine; Body Weight; Cyclophosphamide; Disease Models, Animal; Guinea Pigs; Leukocyte | 1989 |
Steroid withdrawal in cyclosporine-treated living related donor renal transplant recipients.
Topics: Azathioprine; Blood Pressure; Body Weight; Cholesterol; Creatinine; Cyclosporins; Drug Administratio | 1989 |
Complete replacement of methylprednisolone by azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients.
Topics: Antilymphocyte Serum; Azathioprine; Blood Pressure; Body Weight; Cyclosporins; Drug Evaluation; Drug | 1988 |
Cortisone, vitamin A, and wound healing: the importance of measuring wound surface area.
Topics: Administration, Topical; Age Factors; Animals; Azathioprine; Body Weight; Cortisone; Female; Immunos | 1986 |
The effect of azathioprine on phagocytic activity and morphology of reticulo-endothelial organs in mice.
Topics: Animals; Azathioprine; Body Weight; Female; Injections, Intraperitoneal; Liver; Lymph Nodes; Mice; M | 1971 |
The influence of cinanserin and selected pharmacologic agents on experimental allergic encephalomyelitis (EAE).
Topics: 5-Hydroxytryptophan; Amphetamine; Anilides; Animals; Azathioprine; Body Weight; Chlorpheniramine; Ci | 1971 |
Immunosuppressive therapy and anaesthesia.
Topics: Adult; Animals; Antilymphocyte Serum; Azathioprine; Body Weight; Drug Synergism; Guanethidine; Human | 1973 |
Two first degree relatives with dilatation of the colon due to Crohn's disease.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Azathioprine; Body Weight; Colectomy; Colitis, Ulcer | 1973 |
Failure of cytotoxic agents to inhibit the clearance of sensitized erythrocytes.
Topics: Animals; Azathioprine; Body Weight; Cell Survival; Chromium; Cyclophosphamide; Erythrocytes; Guinea | 1974 |
Azathioprine administration to NZB X NZW hybrid mice with lupus nephritis: beneficial effect complicated by development of malignant lymphomas.
Topics: Animals; Autoantibodies; Autoimmune Diseases; Azathioprine; Body Weight; Female; Hodgkin Disease; Ki | 1973 |
Pattern recognition in medicine--a place for the use of principal component analysis and factor analysis.
Topics: Azathioprine; Body Height; Body Weight; Child; Computers; Cyclophosphamide; Diagnosis, Differential; | 1974 |
Hypermetabolic state following renal allotransplantation.
Topics: Appetite; Azathioprine; Basal Metabolism; Blood Urea Nitrogen; Body Weight; Creatinine; Diet; Diet T | 1972 |
[Effect of azathioprine and 6-methylprednisolone on growth, weight increase, blood picture and metabolism of juvenile miniature pigs].
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Azathioprine; Bloo | 1972 |
Influence of classical immunosuppressants on spleen colony formation in mice.
Topics: Animals; Azathioprine; Body Weight; Bone Marrow; Bone Marrow Cells; Cell Count; Cell Division; Clone | 1973 |
Preservation of the small intestine for allotransplantation.
Topics: Animals; Antilymphocyte Serum; Azathioprine; Body Fluids; Body Weight; Chloramphenicol; Chlorpromazi | 1973 |
Experimental allotransplantation of the preserved pancreas and duodenum.
Topics: Amylases; Animals; Azathioprine; Blood Glucose; Blood Proteins; Body Weight; Dogs; Duodenum; Glucose | 1969 |
Kidney transplants: computer display of clinical and laboratory parameters. The first 100 days.
Topics: Azathioprine; Blood Pressure; Blood Urea Nitrogen; Body Weight; Cadaver; Computers; Creatinine; Data | 1969 |
Skin allografts and immunosuppression in the treatment of massive thermal injury.
Topics: Anesthesia, Inhalation; Animals; Antilymphocyte Serum; Azathioprine; Body Weight; Burns; Guinea Pigs | 1969 |
Oliguria following transplantation of kidneys donated by blood relatives.
Topics: Adult; Age Factors; Anuria; Azathioprine; Blood Pressure; Body Weight; Cephalothin; Female; Histocom | 1970 |
The effect of 9-butyl azathioprine on canine renal homograft survival.
Topics: Animals; Azathioprine; Body Weight; Bone Marrow Diseases; Dogs; Graft Rejection; Histocompatibility; | 1971 |
Long-term survivals after allogeneic heart grafts in dogs, physiological, morphological and bio-immunological considerations.
Topics: Acetylcholine; Animals; Antibodies; Antilymphocyte Serum; Atropine; Azathioprine; Body Weight; Creat | 1970 |
Wasting syndrome in thymectomized immature baboons (papio species) after infection with adenovirus type 12.
Topics: Adenoviridae; Alopecia; Animals; Antibody Formation; Azathioprine; Body Weight; Cobalt Isotopes; Com | 1967 |
[Animal experimental studies on the effect of azathioprine on the formation of circulating antibodies].
Topics: Animals; Antibodies; Antibody Formation; Antigens; Azathioprine; Body Weight; Female; Immunodiffusio | 1969 |
Problems in absorption and immunosuppression after entire intestinal allotransplantation.
Topics: Animals; Azathioprine; Body Weight; Dogs; Graft Rejection; Hematocrit; Immunosuppression Therapy; In | 1972 |
Reversal of azathioprine-induced inhibition of hyperplasia in regenerating liver.
Topics: Administration, Oral; Animals; Azathioprine; Body Weight; DNA; Hepatectomy; Hyperplasia; Liver; Live | 1972 |
Biochemical and histological changes following imuran (azathioprine) administration.
Topics: Animals; Azathioprine; Blood Coagulation; Blood Protein Disorders; Body Weight; Bone Marrow; Dogs; K | 1971 |
Function of a transplanted kidney.
Topics: Adult; Azathioprine; Body Weight; Female; Glomerulonephritis; Humans; Immune Tolerance; Kidney; Kidn | 1967 |
Chemotherapy of experimental allergic encephalomyelitis (EAE).
Topics: Allopurinol; Aminocaproates; Analgesics; Animals; Antineoplastic Agents; Azathioprine; Body Weight; | 1969 |
[Biochemical and histological changes resulting from the administration of an immunosuppressive agent, Imuran azathioprine].
Topics: Animals; Azathioprine; Body Weight; Dogs; Liver; Lymph Nodes; Lymphopenia; Serum Albumin | 1970 |
Azathioprine: an adjunct to surgical therapy of granulomatous enteritis.
Topics: Adult; Azathioprine; Blood Proteins; Body Weight; Crohn Disease; Diarrhea; Diet Therapy; Feces; Fema | 1970 |
Chronic toxicity of azathioprine and the effect of this immunosuppressant on liver tumor induction by the carcinogen N-hydroxy-N-2-fluorenylacetamide.
Topics: Amides; Animals; Animals, Laboratory; Azathioprine; Body Weight; Carcinogens; Diet; Female; Liver; L | 1970 |
[Ophthalmological symptomatology, therapy and prognosis of Fuch's and Lyell's syndromes].
Topics: Adult; Azathioprine; Body Weight; Corneal Opacity; Cortisone; Diagnosis, Differential; Entropion; Er | 1970 |
Effectiveness of an interferon stimulator in immunosuppressed mice.
Topics: Animals; Azathioprine; Body Weight; Cyclophosphamide | 1971 |
Immune response to insulin in guinea pigs.
Topics: Adjuvants, Immunologic; Animals; Antibody Formation; Azathioprine; Body Weight; Cattle; Chromatograp | 1971 |